U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851325) titled 'Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes' on Feb. 24.
Brief Summary: The MIRON-PLATELET study is a retrospective, observational multi-center analysis assessing the impact of different antiplatelet therapies on hemorrhagic myocardial infarction (HMI) incidence and outcomes in STEMI patients. Key endpoints include hemorrhagic transformation, MACE, bleeding complications, and 30-day mortality. Findings will offer insights into the safety and clinical implications of antiplatelet therapy in high-risk patients.
Study Start Date: May 01, 2023
Study Type: OBSERVATIONAL
Condition:
STEMI
Acute Myocard...